SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-18-013648
Filing Date
2018-05-15
Accepted
2018-05-15 16:32:52
Documents
6
Period of Report
2018-06-20
Effectiveness Date
2018-05-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A arpo-def14a_20180620.htm DEF 14A 770891
2 GRAPHIC g201805152022468175190.jpg GRAPHIC 99768
3 GRAPHIC g201805152022409735188.jpg GRAPHIC 4050
4 GRAPHIC g201805152022468735192.jpg GRAPHIC 40971
5 GRAPHIC g201805152022409995189.jpg GRAPHIC 4440
6 GRAPHIC g201805152022468455191.jpg GRAPHIC 72599
  Complete submission text file 0001564590-18-013648.txt   1078228
Mailing Address 9987 CARVER ROAD CINCINNATI OH 45242
Business Address 9987 CARVER ROAD CINCINNATI OH 45242 (513) 985-1920
Aerpio Pharmaceuticals, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-53057 | Film No.: 18837089
SIC: 2834 Pharmaceutical Preparations